Culbertson A N & Co’s Thermo Fisher Scientific TMO Stock Holding History

Culbertson A N & Co’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-565	Closed	-$258K	–	113
2021 Q1	$258K	Hold	565	–	–	0.06%	107
2020 Q4	$263K	Hold	565	–	–	0.06%	103
2020 Q3	$249K	Hold	565	–	–	0.07%	103
2020 Q2	$205K	Buy	+565	New	+$189K	0.06%	107

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Culbertson A N & Co's TMO Position: Q2 2021 in Review

Culbertson A N & Co sold out of Thermo Fisher Scientific (TMO) in Q2 2021, closing a stake of 565 shares — an estimated $258K sold.

Culbertson A N & Co first reported a position in TMO in Q2 2020 and held it in 4 quarters. The position peaked at $263K in Q4 2020. 2,074 funds tracked by Wall St. Rank hold TMO as of Q2 2021.

Culbertson A N & Co reported no remaining Thermo Fisher Scientific position as of Q2 2021 after selling out during the quarter.
Culbertson A N & Co sold 565 Thermo Fisher Scientific shares in Q2 2021, an estimated $258K.
Culbertson A N & Co first reported a position in Thermo Fisher Scientific in Q2 2020 and held it in 4 quarters.
Culbertson A N & Co's Thermo Fisher Scientific position peaked at $263K in Q4 2020.
2,074 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.

Based on Culbertson A N & Co's 13F filing for Q2 2021, filed 26 Jul 2021.